South Africa: Aspen in Dutch Pharmaceutical Deal

[SA Info]South Africa’s Aspen Pharmacare has signed a R10-billion deal with Dutch pharmaceutical firm MSD to acquire an active pharmaceutical ingredient (API) manufacturing business in the Netherlands and satellite office in the United States.

Powered by WPeMatico

This entry was posted in Business. Bookmark the permalink.

Comments are closed.